{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:02:42Z","timestamp":1791140562361,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.rmed.2011.10.020","type":"journal-article","created":{"date-parts":[[2011,12,23]],"date-time":"2011-12-23T04:14:01Z","timestamp":1324613641000},"page":"531-539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide\/formoterol in patients with COPD"],"prefix":"10.1016","volume":"106","author":[{"given":"Piotr","family":"Kuna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Fahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2011.10.020_bib1","author":"GOLD"},{"key":"10.1016\/j.rmed.2011.10.020_bib2","series-title":"The global burden of disease 2004 update","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.rmed.2011.10.020_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1055\/s-2005-869535","article-title":"Pathogenesis of COPD","volume":"26","author":"Spurzem","year":"2005","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2011.10.020_bib4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1164\/rccm.200712-1869OC","article-title":"Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study","volume":"178","author":"Celli","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2011.10.020_bib5","doi-asserted-by":"crossref","first-page":"151S","DOI":"10.1378\/chest.121.5_suppl.151S","article-title":"Neutrophils and the pathogenesis of COPD","volume":"121","author":"Stockley","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2011.10.020_bib6","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1073\/pnas.84.8.2228","article-title":"Primary structure of human neutrophil elastase","volume":"84","author":"Sinha","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rmed.2011.10.020_bib7","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1164\/rccm.200202-098OC","article-title":"Synthetic serine elastase inhibitor reduces cigarette smoke-induced emphysema in guinea pigs","volume":"166","author":"Wright","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2011.10.020_bib8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1164\/rccm.2103118","article-title":"A novel oral neutrophil elastase inhibitor (ONO-6818) inhibits human neutrophil elastase-induced emphysema in rats","volume":"166","author":"Kuraki","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2011.10.020_bib9","doi-asserted-by":"crossref","first-page":"31736","DOI":"10.1074\/jbc.M803732200","article-title":"Activation of the epidermal growth factor receptor (EGFR) by a novel metalloprotease pathway","volume":"283","author":"Bergin","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rmed.2011.10.020_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF02256548","article-title":"Neutrophil elastase induces IL-8 synthesis by lung epithelial cells via the mitogen-activated protein kinase pathway","volume":"11","author":"Chen","year":"2004","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.rmed.2011.10.020_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1165\/ajrcmb\/4.1.26","article-title":"Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium","volume":"4","author":"Amitani","year":"1991","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.rmed.2011.10.020_bib12","doi-asserted-by":"crossref","first-page":"L813","DOI":"10.1152\/ajplung.00435.2004","article-title":"Neutrophil elastase activates near-silent epithelial Na+ channels and increases airway epithelial Na+ transport","volume":"288","author":"Caldwell","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.rmed.2011.10.020_bib13","doi-asserted-by":"crossref","first-page":"L1293","DOI":"10.1152\/ajplung.00140.2004","article-title":"Neutrophil elastase induces mucus cell metaplasia in mouse lung","volume":"287","author":"Voynow","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.rmed.2011.10.020_bib14","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.biocel.2008.03.003","article-title":"Proteases and cystic fibrosis","volume":"40","author":"Voynow","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.rmed.2011.10.020_bib15","first-page":"38s","article-title":"Efficacy and safety of AZD9668, an oral neutrophil elastase inhibitor, in idiopathic bronchiectasis","author":"Stockley","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2011.10.020_bib16","doi-asserted-by":"crossref","unstructured":"Elborn JS, Perrett J, Forsman-Semb K, Marks-Konczalik J, Gunawardena K, Entwistle N. Effect of the oral neutrophil elastase inhibitor, AZD9668, in patients with cystic fibrosis. Abstract presented at the 107th Annual Conference of the American Thoracic Society, Denver, Colorado; May 13\u201318\u00a02011.","DOI":"10.1164\/ajrccm-conference.2011.183.1_MeetingAbstracts.A6122"},{"key":"10.1016\/j.rmed.2011.10.020_bib17","first-page":"203s","article-title":"Safety, tolerability and pharmacokinetics of AZD9668, an oral neutrophil elastase inhibitor, in healthy subjects and patients with COPD","author":"Gunawardena","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2011.10.020_bib18","doi-asserted-by":"crossref","first-page":"12941","DOI":"10.1073\/pnas.2235344100","article-title":"The detection and quantitation of free desmosine and isodesmosine in human urine and their peptide-bound forms in sputum","volume":"100","author":"Ma","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rmed.2011.10.020_bib19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.pupt.2005.02.013","article-title":"Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD","volume":"18","author":"Briggs","year":"2005","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.rmed.2011.10.020_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2466-10-11","article-title":"Efficacy and safety of indacaterol 150 microg once-daily in COPD: a double-blind, randomised, 12-week study","volume":"10","author":"Feldman","year":"2010","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.rmed.2011.10.020_bib21","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1164\/rccm.200904-0492OC","article-title":"Efficacy and tolerability of budesonide\/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease","volume":"180","author":"Welte","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2011.10.020_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2466-10-50","article-title":"Does tiotropium lower exacerbation and hospitalization frequency in COPD patients: results of a meta-analysis","volume":"10","author":"Van den","year":"2010","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.rmed.2011.10.020_bib23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2147\/COPD.S17864","article-title":"Tiotropium reduces risk of exacerbations irrespective of previous use of inhaled anticholinergics in placebo-controlled clinical trials","volume":"6","author":"Cooper","year":"2011","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.rmed.2011.10.020_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1465-9921-12-18","article-title":"Reduction of exacerbations by the PDE4 inhibitor roflumilast\u2013the importance of defining different subsets of patients with COPD","volume":"12","author":"Rennard","year":"2011","journal-title":"Respir Res"},{"key":"10.1016\/j.rmed.2011.10.020_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1124\/jpet.111.182139","article-title":"AZD9668: pharmacological characterisation of a novel oral inhibitor of neutrophil elastase","volume":"339","author":"Stevens","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.rmed.2011.10.020_bib26","unstructured":"Stockley RA, Snell N, Perrett J, Gunawardena K. Efficacy and safety of AZD9668, an oral neutrophil elastase inhibitor, in idiopathic bronchiectasis. Abstract presented at the European Respiratory Society Annual Congress, Barcelona, Spain; 18\u201322 September 2010."},{"key":"10.1016\/j.rmed.2011.10.020_bib27","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1016\/S0021-9258(18)50689-X","article-title":"The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center","volume":"254","author":"Johnson","year":"1979","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rmed.2011.10.020_bib28","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.1097\/00003246-200205001-00018","article-title":"Neutrophil elastase and acute lung injury: prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics","volume":"30","author":"Zeiher","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1016\/j.rmed.2011.10.020_bib29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1034\/j.1600-0773.2001.088001040.x","article-title":"Altered expression of lung cytochrome P450 3A1 in rat after exposure to sulfur mustard","volume":"88","author":"Pons","year":"2001","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.rmed.2011.10.020_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1164\/ajrccm\/141.1.47","article-title":"Induction and exacerbation of emphysema in hamsters with human neutrophil elastase inactivated reversibly by a peptide boronic acid","volume":"141","author":"Stone","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.rmed.2011.10.020_bib31","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa032158","article-title":"The nature of small-airway obstruction in chronic obstructive pulmonary disease","volume":"350","author":"Hogg","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmed.2011.10.020_bib32","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1056\/NEJMra0804752","article-title":"Immunologic aspects of chronic obstructive pulmonary disease","volume":"360","author":"Cosio","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmed.2011.10.020_bib33","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1183\/09031936.00067008","article-title":"A hypothesis for the initiation of COPD","volume":"34","author":"Tzortzaki","year":"2009","journal-title":"Eur Respir J"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611111003842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611111003842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:18:18Z","timestamp":1760613498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611111003842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0954611111003842"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2011.10.020","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide\/formoterol in patients with COPD","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2011.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}